{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T06:46:34Z","timestamp":1776321994350,"version":"3.50.1"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2023,8,5]],"date-time":"2023-08-05T00:00:00Z","timestamp":1691193600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,5]],"date-time":"2023-08-05T00:00:00Z","timestamp":1691193600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Australian Vision Research"},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001230","name":"Macquarie University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001230","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Glaucoma is a leading cause of permanent blindness worldwide and is characterized by neurodegeneration linked to progressive retinal ganglion cell (RGC) death, axonal damage, and neuroinflammation. Glutamate excitotoxicity mediated through N-methyl-D-aspartate (NMDA) receptors plays a crucial role in glaucomatous RGC loss. Sphingosine 1-phosphate receptors (S1PRs) are important mediators of neurodegeneration and neuroinflammation in the brain and the retina. Siponimod is an immunomodulatory drug for multiple sclerosis and is a selective modulator of S1PR subtypes 1 and 5 and has been shown to have beneficial effects on the central nervous system (CNS) in degenerative conditions. Our previous study showed that mice administered orally with siponimod protected inner retinal structure and function against acute NMDA excitotoxicity. To elucidate the molecular mechanisms behind these protective effects, we investigated the inflammatory pathways affected by siponimod treatment in NMDA excitotoxicity model. NMDA excitotoxicity resulted in the activation of glial cells coupled with upregulation of the inflammatory NF-kB pathway and increased expression of TNF\u03b1, IL1-\u03b2, and IL-6. Siponimod treatment significantly reduced glial activation and suppressed the pro-inflammatory pathways. Furthermore, NMDA-induced activation of NLRP3 inflammasome and upregulation of neurotoxic inducible nitric oxide synthase (iNOS) were significantly diminished with siponimod treatment. Our data demonstrated that siponimod induces anti-inflammatory effects via suppression of glial activation and inflammatory singling pathways that could protect the retina against acute excitotoxicity conditions. These findings provide insights into the anti-inflammatory effects of siponimod in the CNS and suggest a potential therapeutic strategy for neuroinflammatory conditions.<\/jats:p>","DOI":"10.1007\/s12035-023-03535-0","type":"journal-article","created":{"date-parts":[[2023,8,5]],"date-time":"2023-08-05T07:03:11Z","timestamp":1691218991000},"page":"7222-7237","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Anti-inflammatory Effects of Siponimod in a Mouse Model of Excitotoxicity-Induced Retinal Injury"],"prefix":"10.1007","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0997-0196","authenticated-orcid":false,"given":"Devaraj","family":"Basavarajappa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivek","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nitin","family":"Chitranshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepa","family":"Viswanathan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veer","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roshana","family":"Vander Wall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viswanthram","family":"Palanivel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehdi","family":"Mirzaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuyi","family":"You","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Klistorner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stuart L.","family":"Graham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,8,5]]},"reference":[{"issue":"10108","key":"3535_CR1","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1016\/S0140-6736(17)31469-1","volume":"390","author":"JB Jonas","year":"2017","unstructured":"Jonas JB, Aung T, Bourne RR, Bron AM, Ritch R, Panda-Jonas S (2017) Glaucoma. Lancet (London, England) 390(10108):2183\u20132193","journal-title":"Lancet (London, England)"},{"key":"3535_CR2","doi-asserted-by":"publisher","first-page":"108506","DOI":"10.1016\/j.exer.2021.108506","volume":"205","author":"J Shen","year":"2021","unstructured":"Shen J, Wang Y, Yao K (2021) Protection of retinal ganglion cells in glaucoma: current status and future. Exp Eye Res 205:108506. https:\/\/doi.org\/10.1016\/j.exer.2021.108506","journal-title":"Exp Eye Res"},{"key":"3535_CR3","doi-asserted-by":"publisher","first-page":"100799","DOI":"10.1016\/j.preteyeres.2019.100799","volume":"75","author":"IH Pang","year":"2020","unstructured":"Pang IH, Clark AF (2020) Inducible rodent models of glaucoma. Prog Retin Eye Res 75:100799","journal-title":"Prog Retin Eye Res"},{"key":"3535_CR4","doi-asserted-by":"publisher","first-page":"101817","DOI":"10.1016\/j.pneurobio.2020.101817","volume":"193","author":"A Artero-Castro","year":"2020","unstructured":"Artero-Castro A, Rodriguez-Jimenez FJ, Jendelova P, VanderWall KB, Meyer JS, Erceg S (2020) Glaucoma as a neurodegenerative disease caused by intrinsic vulnerability factors. Prog Neurobiol 193:101817. https:\/\/doi.org\/10.1016\/j.pneurobio.2020.101817","journal-title":"Prog Neurobiol"},{"issue":"7","key":"3535_CR5","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.2174\/1570159x16666180419121247","volume":"16","author":"N Chitranshi","year":"2018","unstructured":"Chitranshi N, Dheer Y, Abbasi M, You Y, Graham SL, Gupta V (2018) Glaucoma pathogenesis and neurotrophins: focus on the molecular and genetic basis for therapeutic prospects. Curr Neuropharmacol 16(7):1018\u20131035. https:\/\/doi.org\/10.2174\/1570159x16666180419121247","journal-title":"Curr Neuropharmacol"},{"key":"3535_CR6","doi-asserted-by":"publisher","first-page":"100916","DOI":"10.1016\/j.preteyeres.2020.100916","volume":"83","author":"C Baudouin","year":"2021","unstructured":"Baudouin C, Kolko M, Melik-Parsadaniantz S, Messmer EM (2021) Inflammation in glaucoma: from the back to the front of the eye, and beyond. Prog Retin Eye Res 83:100916. https:\/\/doi.org\/10.1016\/j.preteyeres.2020.100916","journal-title":"Prog Retin Eye Res"},{"key":"3535_CR7","doi-asserted-by":"publisher","unstructured":"M\u00e9lik Parsadaniantz S, R\u00e9aux-le Goazigo A, Sapienza A, Habas C, Baudouin C (2020) Glaucoma: a degenerative optic neuropathy related to neuroinflammation? Cells 9(3). https:\/\/doi.org\/10.3390\/cells9030535","DOI":"10.3390\/cells9030535"},{"key":"3535_CR8","doi-asserted-by":"publisher","first-page":"612422","DOI":"10.3389\/fneur.2020.612422","volume":"11","author":"T Rolle","year":"2020","unstructured":"Rolle T, Ponzetto A, Malinverni L (2020) The role of neuroinflammation in glaucoma: an update on molecular mechanisms and new therapeutic options. Front Neurol 11:612422. https:\/\/doi.org\/10.3389\/fneur.2020.612422","journal-title":"Front Neurol"},{"key":"3535_CR9","doi-asserted-by":"publisher","first-page":"101169","DOI":"10.1016\/j.preteyeres.2023.101169","volume":"93","author":"Y Miao","year":"2023","unstructured":"Miao Y, Zhao GL, Cheng S, Wang Z, Yang XL (2023) Activation of retinal glial cells contributes to the degeneration of ganglion cells in experimental glaucoma. Prog Retin Eye Res 93:101169. https:\/\/doi.org\/10.1016\/j.preteyeres.2023.101169","journal-title":"Prog Retin Eye Res"},{"issue":"1","key":"3535_CR10","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1186\/s12974-021-02315-8","volume":"18","author":"Q Li","year":"2021","unstructured":"Li Q, Cheng Y, Zhang S, Sun X, Wu J (2021) TRPV4-induced M\u00fcller cell gliosis and TNF-\u03b1 elevation-mediated retinal ganglion cell apoptosis in glaucomatous rats via JAK2\/STAT3\/NF-\u03baB pathway. J Neuroinflammation 18(1):271. https:\/\/doi.org\/10.1186\/s12974-021-02315-8","journal-title":"J Neuroinflammation"},{"key":"3535_CR11","doi-asserted-by":"publisher","first-page":"100998","DOI":"10.1016\/j.preteyeres.2021.100998","volume":"87","author":"G Tezel","year":"2022","unstructured":"Tezel G (2022) Molecular regulation of neuroinflammation in glaucoma: current knowledge and the ongoing search for new treatment targets. Prog Retin Eye Res 87:100998. https:\/\/doi.org\/10.1016\/j.preteyeres.2021.100998","journal-title":"Prog Retin Eye Res"},{"issue":"1","key":"3535_CR12","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s40662-022-00298-y","volume":"9","author":"L Lambuk","year":"2022","unstructured":"Lambuk L, Suhaimi NAA, Sadikan MZ, Jafri AJA, Ahmad S, Nasir NAA, Uskokovi\u0107 V, Kadir R et al (2022) Nanoparticles for the treatment of glaucoma-associated neuroinflammation. Eye Vis (Lond) 9(1):26. https:\/\/doi.org\/10.1186\/s40662-022-00298-y","journal-title":"Eye Vis (Lond)"},{"key":"3535_CR13","doi-asserted-by":"publisher","DOI":"10.2174\/1566524022666220508182051","author":"SC Dur\u00e1n-Cristiano","year":"2022","unstructured":"Dur\u00e1n-Cristiano SC (2022) Glaucoma: biological mechanism and its clinical translation. Curr Mol Med. https:\/\/doi.org\/10.2174\/1566524022666220508182051","journal-title":"Curr Mol Med"},{"key":"3535_CR14","doi-asserted-by":"publisher","unstructured":"Boccuni I, Fairless R (2022) Retinal glutamate neurotransmission: from physiology to pathophysiological mechanisms of retinal ganglion cell degeneration. Life (Basel) 12(5). https:\/\/doi.org\/10.3390\/life12050638","DOI":"10.3390\/life12050638"},{"key":"3535_CR15","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.brainres.2019.02.008","volume":"1714","author":"A Ito","year":"2019","unstructured":"Ito A, Tsuda S, Kunikata H, Toshifumi A, Sato K, Nakazawa T (2019) Assessing retinal ganglion cell death and neuroprotective agents using real time imaging. Brain Res 1714:65\u201372. https:\/\/doi.org\/10.1016\/j.brainres.2019.02.008","journal-title":"Brain Res"},{"issue":"1","key":"3535_CR16","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/j.1442-9071.2006.01146.x","volume":"34","author":"RJ Casson","year":"2006","unstructured":"Casson RJ (2006) Possible role of excitotoxicity in the pathogenesis of glaucoma. Clin Exp Ophthalmol 34(1):54\u201363. https:\/\/doi.org\/10.1111\/j.1442-9071.2006.01146.x","journal-title":"Clin Exp Ophthalmol"},{"key":"3535_CR17","doi-asserted-by":"publisher","unstructured":"Vernazza S, Oddone F, Tirendi S, Bassi AM (2021) Risk factors for retinal ganglion cell distress in glaucoma and neuroprotective potential intervention. Int J Mol Sci 22(15). https:\/\/doi.org\/10.3390\/ijms22157994","DOI":"10.3390\/ijms22157994"},{"issue":"10","key":"3535_CR18","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.1016\/j.bpj.2017.06.035","volume":"113","author":"GJ Iacobucci","year":"2017","unstructured":"Iacobucci GJ, Popescu GK (2017) Resident calmodulin primes NMDA receptors for Ca(2+)-dependent inactivation. Biophys J 113(10):2236\u20132248. https:\/\/doi.org\/10.1016\/j.bpj.2017.06.035","journal-title":"Biophys J"},{"key":"3535_CR19","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1756-6606-6-34","volume":"6","author":"N Bai","year":"2013","unstructured":"Bai N, Aida T, Yanagisawa M, Katou S, Sakimura K, Mishina M, Tanaka K (2013) NMDA receptor subunits have different roles in NMDA-induced neurotoxicity in the retina. Mol Brain 6:34. https:\/\/doi.org\/10.1186\/1756-6606-6-34","journal-title":"Mol Brain"},{"key":"3535_CR20","doi-asserted-by":"publisher","unstructured":"Rodr\u00edguez Villanueva J, Mart\u00edn Esteban J, Rodr\u00edguez Villanueva LJ (2020) Retinal cell protection in ocular excitotoxicity diseases. Possible alternatives offered by microparticulate drug delivery systems and future prospects. Pharmaceutics 12(2). https:\/\/doi.org\/10.3390\/pharmaceutics12020094","DOI":"10.3390\/pharmaceutics12020094"},{"key":"3535_CR21","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.exer.2019.01.018","volume":"181","author":"P Tsoka","year":"2019","unstructured":"Tsoka P, Barbisan PR, Kataoka K, Chen XN, Tian B, Bouzika P, Miller JW, Paschalis EI et al (2019) NLRP3 inflammasome in NMDA-induced retinal excitotoxicity. Exp Eye Res 181:136\u2013144. https:\/\/doi.org\/10.1016\/j.exer.2019.01.018","journal-title":"Exp Eye Res"},{"issue":"2","key":"3535_CR22","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41419-020-2302-x","volume":"11","author":"J Baya Mdzomba","year":"2020","unstructured":"Baya Mdzomba J, Joly S, Rodriguez L, Dirani A, Lassiaz P, Behar-Cohen F, Pernet V (2020) Nogo-A-targeting antibody promotes visual recovery and inhibits neuroinflammation after retinal injury. Cell Death Dis 11(2):101. https:\/\/doi.org\/10.1038\/s41419-020-2302-x","journal-title":"Cell Death Dis"},{"issue":"1","key":"3535_CR23","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1186\/s12974-022-02626-4","volume":"19","author":"M Liu","year":"2022","unstructured":"Liu M, Li H, Yang R, Ji D, Xia X (2022) GSK872 and necrostatin-1 protect retinal ganglion cells against necroptosis through inhibition of RIP1\/RIP3\/MLKL pathway in glutamate-induced retinal excitotoxic model of glaucoma. J Neuroinflammation 19(1):262. https:\/\/doi.org\/10.1186\/s12974-022-02626-4","journal-title":"J Neuroinflammation"},{"key":"3535_CR24","doi-asserted-by":"publisher","unstructured":"Cartier A, Hla T (2019) Sphingosine 1-phosphate: Lipid signaling in pathology and therapy. Science 366(6463). https:\/\/doi.org\/10.1126\/science.aar5551","DOI":"10.1126\/science.aar5551"},{"issue":"Pt B","key":"3535_CR25","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.neuropharm.2016.11.006","volume":"113","author":"S O'Sullivan","year":"2017","unstructured":"O\u2019Sullivan S, Dev KK (2017) Sphingosine-1-phosphate receptor therapies: advances in clinical trials for CNS-related diseases. Neuropharmacology 113(Pt B):597\u2013607. https:\/\/doi.org\/10.1016\/j.neuropharm.2016.11.006","journal-title":"Neuropharmacology"},{"key":"3535_CR26","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.exer.2011.09.023","volume":"103","author":"VK Gupta","year":"2012","unstructured":"Gupta VK, You Y, Klistorner A, Graham SL (2012) Focus on molecules: sphingosine 1 phosphate (S1P). Exp Eye Res 103:119\u2013120. https:\/\/doi.org\/10.1016\/j.exer.2011.09.023","journal-title":"Exp Eye Res"},{"issue":"3","key":"3535_CR27","doi-asserted-by":"publisher","first-page":"344","DOI":"10.3390\/molecules22030344","volume":"22","author":"NJ Pyne","year":"2017","unstructured":"Pyne NJ, Pyne S (2017) Sphingosine 1-phosphate receptor 1 signaling in mammalian cells. Molecules 22(3):344","journal-title":"Molecules"},{"issue":"10127","key":"3535_CR28","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/s0140-6736(18)30475-6","volume":"391","author":"L Kappos","year":"2018","unstructured":"Kappos L, Bar-Or A, Cree BAC, Fox RJ, Giovannoni G, Gold R, Vermersch P, Arnold DL et al (2018) Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study. Lancet (London, England) 391(10127):1263\u20131273. https:\/\/doi.org\/10.1016\/s0140-6736(18)30475-6","journal-title":"Lancet (London, England)"},{"issue":"2","key":"3535_CR29","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1080\/14656566.2018.1551363","volume":"20","author":"L Dumitrescu","year":"2019","unstructured":"Dumitrescu L, Constantinescu CS, Tanasescu R (2019) Siponimod for the treatment of secondary progressive multiple sclerosis. Expert Opin Pharmacother 20(2):143\u2013150. https:\/\/doi.org\/10.1080\/14656566.2018.1551363","journal-title":"Expert Opin Pharmacother"},{"issue":"1","key":"3535_CR30","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3390\/cells8010024","volume":"8","author":"N Behrangi","year":"2019","unstructured":"Behrangi N, Fischbach F, Kipp M (2019) Mechanism of siponimod: anti-inflammatory and neuroprotective mode of action. Cells 8(1):24","journal-title":"Cells"},{"key":"3535_CR31","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-022-00927-z","author":"SL Cohan","year":"2022","unstructured":"Cohan SL, Benedict RHB, Cree BAC, DeLuca J, Hua LH, Chun J (2022) The two sides of siponimod: evidence for brain and immune mechanisms in multiple sclerosis. CNS Drugs. https:\/\/doi.org\/10.1007\/s40263-022-00927-z","journal-title":"CNS Drugs"},{"issue":"4","key":"3535_CR32","doi-asserted-by":"publisher","first-page":"205521732110491","DOI":"10.1177\/20552173211049168","volume":"7","author":"M Bigaud","year":"2021","unstructured":"Bigaud M, Rudolph B, Briard E, Beerli C, Hofmann A, Hermes E, Muellershausen F, Schubart A et al (2021) Siponimod (BAF312) penetrates, distributes, and acts in the central nervous system: preclinical insights. Mult Scler J Exp Transl Clin 7(4):20552173211049170. https:\/\/doi.org\/10.1177\/20552173211049168","journal-title":"Mult Scler J Exp Transl Clin"},{"issue":"4","key":"3535_CR33","doi-asserted-by":"publisher","first-page":"840","DOI":"10.4103\/1673-5374.344952","volume":"18","author":"D Basavarajappa","year":"2023","unstructured":"Basavarajappa D, Gupta V, Chitranshi N, Wall RV, Rajput R, Pushpitha K, Sharma S, Mirzaei M et al (2023) Siponimod exerts neuroprotective effects on the retina and higher visual pathway through neuronal S1PR1 in experimental glaucoma. Neural Regen Res 18(4):840\u2013848. https:\/\/doi.org\/10.4103\/1673-5374.344952","journal-title":"Neural Regen Res"},{"key":"3535_CR34","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.expneurol.2019.01.015","volume":"314","author":"Y Dheer","year":"2019","unstructured":"Dheer Y, Chitranshi N, Gupta V, Sharma S, Pushpitha K, Abbasi M, Mirzaei M, You Y et al (2019) Retinoid x receptor modulation protects against ER stress response and rescues glaucoma phenotypes in adult mice. Exp Neurol 314:111\u2013125. https:\/\/doi.org\/10.1016\/j.expneurol.2019.01.015","journal-title":"Exp Neurol"},{"issue":"2","key":"3535_CR35","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.ymthe.2018.09.019","volume":"27","author":"N Chitranshi","year":"2019","unstructured":"Chitranshi N, Dheer Y, Mirzaei M, Wu Y, Salekdeh GH, Abbasi M, Gupta V, Vander Wall R et al (2019) Loss of Shp2 rescues BDNF\/TrkB signaling and contributes to improved retinal ganglion cell neuroprotection. Mol Ther 27(2):424\u2013441. https:\/\/doi.org\/10.1016\/j.ymthe.2018.09.019","journal-title":"Mol Ther"},{"issue":"13","key":"3535_CR36","doi-asserted-by":"publisher","first-page":"6154","DOI":"10.7150\/thno.55472","volume":"11","author":"M Abbasi","year":"2021","unstructured":"Abbasi M, Gupta VK, Chitranshi N, Gupta V, Ranjbaran R, Rajput R, Pushpitha K, Kb D et al (2021) Inner retinal injury in experimental glaucoma is prevented upon AAV mediated Shp2 silencing in a caveolin dependent manner. Theranostics 11(13):6154\u20136172. https:\/\/doi.org\/10.7150\/thno.55472","journal-title":"Theranostics"},{"key":"3535_CR37","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.neuroscience.2022.01.020","volume":"490","author":"V Gupta","year":"2022","unstructured":"Gupta V, Chitranshi N, Gupta V, You Y, Rajput R, Paulo JA, Mirzaei M, van den Buuse M et al (2022) TrkB receptor agonist 7,8 dihydroxyflavone is protective against the inner retinal deficits induced by experimental glaucoma. Neuroscience 490:36\u201348. https:\/\/doi.org\/10.1016\/j.neuroscience.2022.01.020","journal-title":"Neuroscience"},{"issue":"9","key":"3535_CR38","doi-asserted-by":"publisher","first-page":"3759","DOI":"10.1007\/s12035-020-01948-9","volume":"57","author":"M Abbasi","year":"2020","unstructured":"Abbasi M, Gupta VK, Chitranshi N, Gupta VB, Mirzaei M, Dheer Y, Garthwaite L, Zaw T et al (2020) Caveolin-1 ablation imparts partial protection against inner retinal injury in experimental glaucoma and reduces apoptotic activation. Mol Neurobiol 57(9):3759\u20133784","journal-title":"Mol Neurobiol"},{"key":"3535_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2023.03.008","author":"N Chitranshi","year":"2023","unstructured":"Chitranshi N, Rajput R, Godinez A, Pushpitha K, Mirzaei M, Basavarajappa D, Gupta V, Sharma S et al (2023) Neuroserpin gene therapy inhibits retinal ganglion cell apoptosis and promotes functional preservation in glaucoma. Mol Ther. https:\/\/doi.org\/10.1016\/j.ymthe.2023.03.008","journal-title":"Mol Ther"},{"issue":"5","key":"3535_CR40","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.biochi.2008.01.004","volume":"90","author":"VK Gupta","year":"2008","unstructured":"Gupta VK, Gowda LR (2008) Alpha-1-proteinase inhibitor is a heparin binding serpin: molecular interactions with the Lys rich cluster of helix-F domain. Biochimie 90(5):749\u2013761. https:\/\/doi.org\/10.1016\/j.biochi.2008.01.004","journal-title":"Biochimie"},{"issue":"19","key":"3535_CR41","doi-asserted-by":"publisher","first-page":"3975","DOI":"10.1128\/mcb.05659-11","volume":"31","author":"DK Basavarajappa","year":"2011","unstructured":"Basavarajappa DK, Gupta VK, Dighe R, Rajala A, Rajala RV (2011) Phosphorylated Grb14 is an endogenous inhibitor of retinal protein tyrosine phosphatase 1B, and light-dependent activation of Src phosphorylates Grb14. Mol Cell Biol 31(19):3975\u20133987. https:\/\/doi.org\/10.1128\/mcb.05659-11","journal-title":"Mol Cell Biol"},{"issue":"11","key":"3535_CR42","doi-asserted-by":"publisher","first-page":"E1363","DOI":"10.1152\/ajpendo.00199.2012","volume":"303","author":"VK Gupta","year":"2012","unstructured":"Gupta VK, Rajala A, Rajala RV (2012) Insulin receptor regulates photoreceptor CNG channel activity. Am J Physiol Endocrinol Metab 303(11):E1363-1372. https:\/\/doi.org\/10.1152\/ajpendo.00199.2012","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"10","key":"3535_CR43","doi-asserted-by":"publisher","first-page":"918","DOI":"10.2174\/1570159x18666200207120949","volume":"18","author":"S Singh","year":"2020","unstructured":"Singh S, Singh TG (2020) Role of Nuclear Factor Kappa B (NF-\u03baB) Signalling in neurodegenerative diseases: a mechanistic approach. Curr Neuropharmacol 18(10):918\u2013935. https:\/\/doi.org\/10.2174\/1570159x18666200207120949","journal-title":"Curr Neuropharmacol"},{"key":"3535_CR44","doi-asserted-by":"publisher","DOI":"10.1111\/ejn.15242","author":"M Dolatshahi","year":"2021","unstructured":"Dolatshahi M, Ranjbar Hameghavandi MH, Sabahi M, Rostamkhani S (2021) Nuclear factor-kappa B (NF-\u03baB) in pathophysiology of Parkinson disease: diverse patterns and mechanisms contributing to neurodegeneration. Eur J Neurosci. https:\/\/doi.org\/10.1111\/ejn.15242","journal-title":"Eur J Neurosci"},{"key":"3535_CR45","doi-asserted-by":"publisher","first-page":"111428","DOI":"10.1016\/j.biopha.2021.111428","volume":"138","author":"YS Feng","year":"2021","unstructured":"Feng YS, Tan ZX, Wu LY, Dong F, Zhang F (2021) The involvement of NLRP3 inflammasome in the treatment of neurodegenerative diseases. Biomed Pharmacother 138:111428. https:\/\/doi.org\/10.1016\/j.biopha.2021.111428","journal-title":"Biomed Pharmacother"},{"key":"3535_CR46","doi-asserted-by":"publisher","unstructured":"Coyle S, Khan MN, Chemaly M, Callaghan B, Doyle C, Willoughby CE, Atkinson SD, Gregory-Ksander M et al (2021) Targeting the NLRP3 Inflammasome in glaucoma. Biomolecules 11(8). https:\/\/doi.org\/10.3390\/biom11081239","DOI":"10.3390\/biom11081239"},{"key":"3535_CR47","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3389\/fncel.2017.00063","volume":"11","author":"L Song","year":"2017","unstructured":"Song L, Pei L, Yao S, Wu Y, Shang Y (2017) NLRP3 inflammasome in neurological diseases, from functions to therapies. Front Cell Neurosci 11:63. https:\/\/doi.org\/10.3389\/fncel.2017.00063","journal-title":"Front Cell Neurosci"},{"key":"3535_CR48","doi-asserted-by":"publisher","first-page":"17023","DOI":"10.1038\/sigtrans.2017.23","volume":"2","author":"T Liu","year":"2017","unstructured":"Liu T, Zhang L, Joo D, Sun SC (2017) NF-\u03baB signaling in inflammation. Signal Transduct Target Ther 2:17023. https:\/\/doi.org\/10.1038\/sigtrans.2017.23","journal-title":"Signal Transduct Target Ther"},{"key":"3535_CR49","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1111\/j.1749-6632.2002.tb04077.x","volume":"962","author":"B Liu","year":"2002","unstructured":"Liu B, Gao HM, Wang JY, Jeohn GH, Cooper CL, Hong JS (2002) Role of nitric oxide in inflammation-mediated neurodegeneration. Ann N Y Acad Sci 962:318\u2013331. https:\/\/doi.org\/10.1111\/j.1749-6632.2002.tb04077.x","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"3535_CR50","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1002\/med.21599","volume":"40","author":"MA Cinelli","year":"2020","unstructured":"Cinelli MA, Do HT, Miley GP, Silverman RB (2020) Inducible nitric oxide synthase: Regulation, structure, and inhibition. Med Res Rev 40(1):158\u2013189. https:\/\/doi.org\/10.1002\/med.21599","journal-title":"Med Res Rev"},{"issue":"3","key":"3535_CR51","doi-asserted-by":"publisher","first-page":"391","DOI":"10.4103\/1673-5374.245465","volume":"14","author":"A Adornetto","year":"2019","unstructured":"Adornetto A, Russo R, Parisi V (2019) Neuroinflammation as a target for glaucoma therapy. Neural Regen Res 14(3):391\u2013394. https:\/\/doi.org\/10.4103\/1673-5374.245465","journal-title":"Neural Regen Res"},{"issue":"1","key":"3535_CR52","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.cell.2009.01.038","volume":"137","author":"K Saijo","year":"2009","unstructured":"Saijo K, Winner B, Carson CT, Collier JG, Boyer L, Rosenfeld MG, Gage FH, Glass CK (2009) A Nurr1\/CoREST pathway in microglia and astrocytes protects dopaminergic neurons from inflammation-induced death. Cell 137(1):47\u201359. https:\/\/doi.org\/10.1016\/j.cell.2009.01.038","journal-title":"Cell"},{"issue":"3","key":"3535_CR53","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.3390\/cimb44030083","volume":"44","author":"F Montarolo","year":"2022","unstructured":"Montarolo F, Martire S, Marnetto F, Valentino P, Valverde S, Capobianco MA, Bertolotto A (2022) The selective agonist for sphingosine-1-phosphate receptors siponimod increases the expression level of NR4A genes in microglia cell line. Curr Issues Mol Biol 44(3):1247\u20131256. https:\/\/doi.org\/10.3390\/cimb44030083","journal-title":"Curr Issues Mol Biol"},{"issue":"28","key":"3535_CR54","doi-asserted-by":"publisher","first-page":"e2202256119","DOI":"10.1073\/pnas.2202256119","volume":"119","author":"PL Yao","year":"2022","unstructured":"Yao PL, Parmar VM, Choudhary M, Malek G (2022) NURR1 expression regulates retinal pigment epithelial-mesenchymal transition and age-related macular degeneration phenotypes. Proc Natl Acad Sci U S A 119(28):e2202256119. https:\/\/doi.org\/10.1073\/pnas.2202256119","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1\u20132","key":"3535_CR55","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/s0169-328x(02)00553-3","volume":"109","author":"A Laabich","year":"2002","unstructured":"Laabich A, Li G, Cooper NG (2002) Enhanced expression of TNF-R1 protein in NMDA-mediated cell death in the retina. Brain Res Mol Brain Res 109(1\u20132):239\u2013246. https:\/\/doi.org\/10.1016\/s0169-328x(02)00553-3","journal-title":"Brain Res Mol Brain Res"},{"issue":"1","key":"3535_CR56","doi-asserted-by":"publisher","first-page":"6885","DOI":"10.1038\/s41598-017-06969-4","volume":"7","author":"S Maekawa","year":"2017","unstructured":"Maekawa S, Sato K, Fujita K, Daigaku R, Tawarayama H, Murayama N, Moritoh S, Yabana T et al (2017) The neuroprotective effect of hesperidin in NMDA-induced retinal injury acts by suppressing oxidative stress and excessive calpain activation. Sci Rep 7(1):6885. https:\/\/doi.org\/10.1038\/s41598-017-06969-4","journal-title":"Sci Rep"},{"key":"3535_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.jphs.2017.09.031","author":"K Sakamoto","year":"2017","unstructured":"Sakamoto K, Okuwaki T, Ushikubo H, Mori A, Nakahara T, Ishii K (2017) Activation inhibitors of nuclear factor kappa B protect neurons against the NMDA-induced damage in the rat retina. J Pharmacol Sci. https:\/\/doi.org\/10.1016\/j.jphs.2017.09.031","journal-title":"J Pharmacol Sci"},{"issue":"11","key":"3535_CR58","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1007\/s40263-020-00771-z","volume":"34","author":"LJ Scott","year":"2020","unstructured":"Scott LJ (2020) Siponimod: a review in secondary progressive multiple sclerosis. CNS Drugs 34(11):1191\u20131200. https:\/\/doi.org\/10.1007\/s40263-020-00771-z","journal-title":"CNS Drugs"},{"issue":"8","key":"3535_CR59","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.3390\/cells9081771","volume":"9","author":"M Kipp","year":"2020","unstructured":"Kipp M (2020) Does siponimod exert direct effects in the central nervous system? Cells 9(8):1771","journal-title":"Cells"},{"issue":"12","key":"3535_CR60","doi-asserted-by":"publisher","first-page":"3336","DOI":"10.1161\/STROKEAHA.117.018505","volume":"48","author":"C Qin","year":"2017","unstructured":"Qin C, Fan W-H, Liu Q, Shang K, Murugan M, Wu L-J, Wang W, Tian D-S (2017) Fingolimod protects against ischemic white matter damage by modulating microglia toward M2 polarization via STAT3 pathway. Stroke 48(12):3336\u20133346","journal-title":"Stroke"},{"issue":"8","key":"3535_CR61","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1073\/pnas.1615413114","volume":"114","author":"V Rothhammer","year":"2017","unstructured":"Rothhammer V, Kenison JE, Tjon E, Takenaka MC, de Lima KA, Borucki DM, Chao CC, Wilz A et al (2017) Sphingosine 1-phosphate receptor modulation suppresses pathogenic astrocyte activation and chronic progressive CNS inflammation. Proc Natl Acad Sci U S A 114(8):2012\u20132017. https:\/\/doi.org\/10.1073\/pnas.1615413114","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3535_CR62","doi-asserted-by":"publisher","first-page":"635","DOI":"10.3389\/fimmu.2020.00635","volume":"11","author":"E Colombo","year":"2020","unstructured":"Colombo E, Bassani C, De Angelis A, Ruffini F, Ottoboni L, Comi G, Martino G, Farina C (2020) Siponimod (BAF312) activates Nrf2 while hampering NF\u03baB in human astrocytes, and protects from astrocyte-induced neurodegeneration. Front Immunol 11:635. https:\/\/doi.org\/10.3389\/fimmu.2020.00635","journal-title":"Front Immunol"},{"issue":"7","key":"3535_CR63","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1007\/s11011-021-00806-4","volume":"36","author":"A Mishra","year":"2021","unstructured":"Mishra A, Bandopadhyay R, Singh PK, Mishra PS, Sharma N, Khurana N (2021) Neuroinflammation in neurological disorders: pharmacotherapeutic targets from bench to bedside. Metab Brain Dis 36(7):1591\u20131626. https:\/\/doi.org\/10.1007\/s11011-021-00806-4","journal-title":"Metab Brain Dis"},{"key":"3535_CR64","doi-asserted-by":"publisher","unstructured":"Voet S, Srinivasan S, Lamkanfi M, van Loo G (2019) Inflammasomes in neuroinflammatory and neurodegenerative diseases. EMBO Mol Med 11(6). https:\/\/doi.org\/10.15252\/emmm.201810248","DOI":"10.15252\/emmm.201810248"},{"key":"3535_CR65","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.neures.2022.08.003","volume":"184","author":"A Ogasawara","year":"2022","unstructured":"Ogasawara A, Takeuchi H, Komiya H, Ogawa Y, Nishimura K, Kubota S, Hashiguchi S, Takahashi K et al (2022) Anti-inflammatory effects of siponimod on astrocytes. Neurosci Res 184:38\u201346. https:\/\/doi.org\/10.1016\/j.neures.2022.08.003","journal-title":"Neurosci Res"},{"issue":"1","key":"3535_CR66","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/s12974-016-0686-4","volume":"13","author":"A Gentile","year":"2016","unstructured":"Gentile A, Musella A, Bullitta S, Fresegna D, De Vito F, Fantozzi R, Piras E, Gargano F et al (2016) Siponimod (BAF312) prevents synaptic neurodegeneration in experimental multiple sclerosis. J Neuroinflammation 13(1):207. https:\/\/doi.org\/10.1186\/s12974-016-0686-4","journal-title":"J Neuroinflammation"},{"issue":"3","key":"3535_CR67","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1080\/14728222.2017.1279146","volume":"21","author":"R Rodr\u00edguez-Calvo","year":"2017","unstructured":"Rodr\u00edguez-Calvo R, Tajes M, V\u00e1zquez-Carrera M (2017) The NR4A subfamily of nuclear receptors: potential new therapeutic targets for the treatment of inflammatory diseases. Expert Opin Ther Targets 21(3):291\u2013304. https:\/\/doi.org\/10.1080\/14728222.2017.1279146","journal-title":"Expert Opin Ther Targets"},{"issue":"5","key":"3535_CR68","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.survophthal.2021.02.003","volume":"66","author":"L Quaranta","year":"2021","unstructured":"Quaranta L, Bruttini C, Micheletti E, Konstas AGP, Michelessi M, Oddone F, Katsanos A, Sbardella D et al (2021) Glaucoma and neuroinflammation: an overview. Surv Ophthalmol 66(5):693\u2013713. https:\/\/doi.org\/10.1016\/j.survophthal.2021.02.003","journal-title":"Surv Ophthalmol"},{"issue":"5","key":"3535_CR69","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1038\/s41433-018-0318-6","volume":"33","author":"C Lin","year":"2019","unstructured":"Lin C, Wu F, Zheng T, Wang X, Chen Y, Wu X (2019) Kaempferol attenuates retinal ganglion cell death by suppressing NLRP1\/NLRP3 inflammasomes and caspase-8 via JNK and NF-\u03baB pathways in acute glaucoma. Eye (Lond) 33(5):777\u2013784. https:\/\/doi.org\/10.1038\/s41433-018-0318-6","journal-title":"Eye (Lond)"},{"key":"3535_CR70","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1134\/S1819712421020045","volume":"15","author":"I Babkina","year":"2021","unstructured":"Babkina I, Sergeeva S, Gorbacheva L (2021) The role of NF-\u03baB in neuroinflammation. Neurochem J 15:114\u2013128","journal-title":"Neurochem J"},{"key":"3535_CR71","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3389\/fnmol.2015.00077","volume":"8","author":"RH Shih","year":"2015","unstructured":"Shih RH, Wang CY, Yang CM (2015) NF-kappaB signaling pathways in neurological inflammation: a mini review. Front Mol Neurosci 8:77. https:\/\/doi.org\/10.3389\/fnmol.2015.00077","journal-title":"Front Mol Neurosci"},{"issue":"4","key":"3535_CR72","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.neuron.2018.01.021","volume":"97","author":"C Baecher-Allan","year":"2018","unstructured":"Baecher-Allan C, Kaskow BJ, Weiner HL (2018) Multiple sclerosis: mechanisms and immunotherapy. Neuron 97(4):742\u2013768. https:\/\/doi.org\/10.1016\/j.neuron.2018.01.021","journal-title":"Neuron"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-023-03535-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-023-03535-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-023-03535-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T15:33:02Z","timestamp":1700494382000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-023-03535-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,5]]},"references-count":72,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["3535"],"URL":"https:\/\/doi.org\/10.1007\/s12035-023-03535-0","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,5]]},"assertion":[{"value":"9 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experimental work performed in his study was approved by the Animal Ethics Committee at Macquarie University. All animal experiments were conducted in accordance with the Australian Code of Practice for the Care and Use of Animals for Scientific Purposes and Macquarie University guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"All authors have agreed to publish this article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}